Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-25-053274
Filing Date
2025-06-11
Accepted
2025-06-11 08:00:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0245310-424b5_citius.htm 424B5 381738
2 GRAPHIC image_001.jpg GRAPHIC 5389
  Complete submission text file 0001213900-25-053274.txt   390513
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-277319 | Film No.: 251038807
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)